LILLE, France–At the 15th Annual Society for Biomolecular Sciences (SBS) Conference , PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of 16 new G-protein coupled receptor (GPCR) and ion channel cell lines. With these latest offerings, PerkinElmer’s GPCR cell lines portfolio is now increased to over 300.

The new cell line offering further expands the company’s leading position in validated cell lines for use in researching diseases, including cancer, inflammation, metabolic and central nervous system disorders.

“PerkinElmer has long been a leader in providing life science researchers with an extensive offering in GPCR technologies, including validated cell lines, detection reagents, and instruments that provide the mainstay of most cell based screening assays. In addition, we also provide a set of recombinant cell lines for use in ion channel research,” said Richard M. Eglen, PhD, president, Bio-discovery, PerkinElmer. “GPCRs are implicated in over one third of all known disease states, and are widely recognized to be proven drug discovery targets. These new GPCR and ion channel cell lines from PerkinElmer will provide customers with additional tools to generate novel therapeutic compounds in many areas of drug discovery.”

PerkinElmer’s latest GPCRs and ion channels cell lines release comprises:

Family Receptor Type

GPCRs GPR GPR120

Protease Activated PAR4

Lysophospholipid S1P2 (Edg5)

Urotensin rUT

Serotonin 5-HT3A

Glucagon GLP-2

Prokineticin PKR2

GPR GPR91

Glucagon Secretin

Dopamine D2L

Purinergic P2Y11

GPR GPR1

NeuropeptideFF NPFF1

Ion channels Voltage gated potassium channel Kv1.3 (KCNA3)

Transient receptor potential channel TRPC3 cell line

Transient receptor potential channel TRPC6 cell line

For a complete listing of PerkinElmer’s GPCR cell lines offering, please visit: www.perkinelmer.com/GPCR

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.